Our results demonstrate that driver mutations (additional to the BCR::ABL1 mutation) are necessary to explain CML progression if stem cells divide sufficiently slowly. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.